Lord, Abbett & Co

Lord, Abbett & Co’s Adaptimmune Therapeutics ADAP Stock Holding History

Lord, Abbett & Co’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$2.52M	Sell
2020 Q3	$3.86M	Sell
2020 Q2	$5.08M	Buy
2015 Q4	–	Sell
2015 Q3	$1.33M	Sell
2015 Q2	$4.57M	Buy